Home/Filings/4/0001741987-25-000010
4//SEC Filing

Burnett Patrick 4

Accession 0001741987-25-000010

CIK 0001787306other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:53 PM ET

Size

9.9 KB

Accession

0001741987-25-000010

Insider Transaction Report

Form 4
Period: 2025-12-15
Burnett Patrick
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15$3.64/sh+11,500$41,860109,807 total
  • Sale

    Common Stock

    2025-12-15$28.94/sh11,500$332,85198,307 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-12-1511,500143,750 total
    Exercise: $3.64Exp: 2034-01-12Common Stock (11,500 underlying)
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.
  • [F2]Due to a scrivener's error on the Reporting Person's Form 4 filed on November 5, 2025, the number of shares of common stock beneficially owned by the Reporting Person was inadvertently overstated by 18 shares. The corrected number of shares beneficially owned is reflected in this Form 4.
  • [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.61 to $29.20, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F4]On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001741987

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:53 PM ET
Size
9.9 KB